Ok it's an infomercial but a well presented piece, far and away the most stylish promotional material PAA has managed thus far.
Dr Aston comes across well. Making explicit that we're dealing with a new class of drug and the potential of the mTOR pathway should generate some interest.
Time frames for phase 2 human and next stage canine trials will help particularly if a trial partner in the US can be established.
PharmAust: Developing Targeted Cancer Therapy, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $86.33M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.8¢ | $30.60K | 170.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 171511 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 197928 | 5 |
View Market Depth
| Last trade - 11.55am 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |